Presentation is loading. Please wait.

Presentation is loading. Please wait.

PUBLISH ONLY Journal of Thoracic Oncology

Published byLynette Wells Modified over 6 years ago

Similar presentations

Presentation on theme: "PUBLISH ONLY Journal of Thoracic Oncology"— Presentation transcript:

1 PUBLISH ONLY Journal of Thoracic Oncology
Journal of Thoracic Oncology  Volume 10, Issue 9, Pages S761-S790 (September 2015) DOI: /S (16) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

2 fig. 1 A: arrival; B: away; C: near; D: far. Conclusion: Adjuvant therapy and depth of invasion are independent factors influencing prognosis of en-bloc resected chest wall involving non-small cell lung cancers, the role of tumor's location needs more investigations. Journal of Thoracic Oncology  , S761-S790DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

3 Journal of Thoracic Oncology 2015 10, S761-S790DOI: (10
Journal of Thoracic Oncology  , S761-S790DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

4 Journal of Thoracic Oncology 2015 10, S761-S790DOI: (10
Journal of Thoracic Oncology  , S761-S790DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

5 Figure 1 overall survival for initial diagnosis among patients with bone metastasis, extraosseous metastasis at diagnosis, both bone and extraosseous metastasis at diagnosis, and only bone metastasis at diagnosis. Journal of Thoracic Oncology  , S761-S790DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

6 Journal of Thoracic Oncology 2015 10, S761-S790DOI: (10
Journal of Thoracic Oncology  , S761-S790DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

7 Journal of Thoracic Oncology 2015 10, S761-S790DOI: (10
Journal of Thoracic Oncology  , S761-S790DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

8 Journal of Thoracic Oncology 2015 10, S761-S790DOI: (10
Journal of Thoracic Oncology  , S761-S790DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

9 Journal of Thoracic Oncology 2015 10, S761-S790DOI: (10
Journal of Thoracic Oncology  , S761-S790DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

10 Journal of Thoracic Oncology 2015 10, S761-S790DOI: (10
Journal of Thoracic Oncology  , S761-S790DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

11 Journal of Thoracic Oncology 2015 10, S761-S790DOI: (10
Journal of Thoracic Oncology  , S761-S790DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

12 Journal of Thoracic Oncology 2015 10, S761-S790DOI: (10
Journal of Thoracic Oncology  , S761-S790DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

13 Journal of Thoracic Oncology 2015 10, S761-S790DOI: (10
Journal of Thoracic Oncology  , S761-S790DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

14 Journal of Thoracic Oncology 2015 10, S761-S790DOI: (10
Journal of Thoracic Oncology  , S761-S790DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

15 Figure 1 The relationship between the modified Glasgow prognostic score [score: 0, 1, 2 from top to bottom) and overall survival in patients with limited-stage small cell lung cancer (p = 0.046). Journal of Thoracic Oncology  , S761-S790DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

16 Figure 2 The relationship between the CPR combined with LDH (score: 0, 1, 2, from top to bottom) and overall survival in patients with limited-stage small cell lung cancer [p=0.003). Journal of Thoracic Oncology  , S761-S790DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

17 Journal of Thoracic Oncology 2015 10, S761-S790DOI: (10
Journal of Thoracic Oncology  , S761-S790DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

18 Journal of Thoracic Oncology 2015 10, S761-S790DOI: (10
Journal of Thoracic Oncology  , S761-S790DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "PUBLISH ONLY Journal of Thoracic Oncology"

Similar presentations

Frances A Shepherd, MD, Rafael Rosell, MD  Journal of Thoracic Oncology 

Frances A Shepherd, MD, Rafael Rosell, MD  Journal of Thoracic Oncology 
A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.

A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,

Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.
Ratio of Metastatic Lymph Nodes to Total Number of Nodes Resected is Prognostic for Survival in Esophageal Carcinoma  Clive J. Kelty, MB, ChB, PhD, FRCSEd,

Ratio of Metastatic Lymph Nodes to Total Number of Nodes Resected is Prognostic for Survival in Esophageal Carcinoma  Clive J. Kelty, MB, ChB, PhD, FRCSEd,
E13-01: Insights into thymic epithelial tumor: pathology

E13-01: Insights into thymic epithelial tumor: pathology
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
SC17.02 Lung Cancer in China: Challenges and Perspectives

SC17.02 Lung Cancer in China: Challenges and Perspectives
Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,
Brett W. Carter, MD, Edith M. Marom, MD, Frank C. Detterbeck, MD 

Brett W. Carter, MD, Edith M. Marom, MD, Frank C. Detterbeck, MD 
APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26

APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Ellen M. Schultz, MS, Gerard A. Silvestri, MD, MS, Michael K

Ellen M. Schultz, MS, Gerard A. Silvestri, MD, MS, Michael K
Tetsuya Mitsudomi, MD, Hirohito Tada, MD  Journal of Thoracic Oncology 

Tetsuya Mitsudomi, MD, Hirohito Tada, MD  Journal of Thoracic Oncology 
NA  Journal of Thoracic Oncology 

NA  Journal of Thoracic Oncology 
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology

IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer  Peter Goldstraw, MB, FRCS, John J. Crowley, PhD 

The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer  Peter Goldstraw, MB, FRCS, John J. Crowley, PhD 
Samuel J. Wang, MD, PhD, C David Fuller, MD, Charles R. Thomas, MD 

Samuel J. Wang, MD, PhD, C David Fuller, MD, Charles R. Thomas, MD 
Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Similar presentations

Ads by Google